Evidence map›Paper›PMID 30934670›Full record

ReviewInternational journal of molecular sciences2019

Resveratrol and Its Effects on the Vascular System.

Johannes M Breuss, Atanas G Atanasov, Pavel Uhrin

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07395921 (Effects of Resveratrol Supplementation on Inflammatory Biomarkers and Cardiometabolic Parameters in Community-dwelling Adults.), which is not on this map. Cited by 161 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 7 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07395921 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effects of Resveratrol Supplementation on Inflammatory Biomarkers and Cardiometabolic Parameters in Community-dwelling Adults. (RESINCA-trial)

TypeinterventionalSponsorCenter for Research and Innovation Viña Concha y ToroRan2026 to 2026Enrolled75ConditionsInflammation Biomarkers, Cardiometabolic Health Indicators, Antioxidant Status, Inflammation, Antioxidant CapabilitiesArmsRES 120, RES 250, RES 500
3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 7 syntheses or guidelines pooled it, 321 citations in OpenAlex.

  1. Pooled it
  2. The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.Cardiovascular & hematological disorders drug targets · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Therapeutic Potential of Plant Phenolic Acids Combating Cancer Drug Resistance.Recent advances in food, nutrition & agriculture · 2026
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Johannes M BreussDepartment of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria. Johannes.Breuss@meduniwien.ac.at.
Atanas G AtanasovDepartment of Molecular Biology, Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzębiec, 05-552 Magdalenka, Poland. Atanas.Atanasov@univie.ac.at.ORCID 0000-0003-2545-0967
Pavel UhrinDepartment of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria. pavel.uhrin@meduniwien.ac.at.ORCID 0000-0002-9792-3420
Medical University of Vienna · ATUniversity of Vienna · AT

Funding

Austrian Science Fund FWF P 31743
6 · The paper itself

Abstract

Resveratrol, the phenolic substance isolated initially from

Indexed as

AnimalsCardiotonic AgentsCardiovascular DiseasesCardiovascular SystemClinical Trials as TopicDisease Models, AnimalHumansResveratrolCardiotonic AgentsResveratrolcardiovascular diseaseclinical studiesresveratrolvasculoprotective effects

Identifiers

PMID30934670
PMCPMC6479680
OpenAlexW2923094111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.